Remote Patient Monitoring (RPM) devices allow healthcare providers to monitor, report, and analyze patients’ health vitals from outside the hospital settings. With real-time monitoring of a patient’s health condition, these devices help clinicians, physicians, and healthcare providers in making proactive clinical decisions and timely interventions.
Adhering to the Food and Drug Administration (FDA) compliance is a critical requirement for cellular enabled RPM devices. To avoid discrepancies, manufacturing defects, and other connection problems, there are several compliance laws that need to be followed. Though all remote patient monitoring devices must comply with HIPAA security and compliance standards, not all of them meet the FDA standards. Some key considerations regarding FDA standards for RPM devices are:
Table of Contents
ToggleFDA-approved remote patient monitoring devices are greatly transforming the modern day healthcare industry by enhancing patient engagement, improving clinical outcomes, and access to care. As RPM continues to evolve, staying informed about new monitoring devices can help optimize patient care and adapt to the changing healthcare environment.
With HealthArc’s remote patient monitoring devices, physicians can manage patients’ daily healthcare data and provide them the right care, support, and interventions. Our digital health platform automatically tracks the vitals of the patients and updates the healthcare professional’s dashboard by generating the patient’s clinical report. Book a demo or call us at (201) 885 5571 for more information.
FDA-cleared devices (Class II medical devices) usually undergo what is called the 510(k) process, which determines safety and effectiveness based on comparison to existing devices. “FDA-approved” is only applicable to higher-risk Class III devices which undergo a more thorough process. Terms could be misquoted, so checking the approval status with the FDA Devices database is a must.
RPM devices must be a medical device in the eyes of the FDA, which includes measuring some area of physiological data and transmitting it to the provider remotely, to guarantee precision, safety, and will be accepted for reimbursement. Devices that do not abide could put data accuracy along with billing approval at risk.
Cellular-enabled RPM device makers must comply with the QSR, its labeling requirements, and 510(k) for Class II devices. In addition, they must uphold the standards of the HIPAA privacy rule.
RPM services (CPT codes 99453 and 99454) tracking and monitoring equipment is often reimbursed by Medicare and numerous private health insurance providers abandoning RPM service tracking and monitoring equipment that is not FDA cleared may result in loss of reimbursement.
Blood pressure cuffs, glucose meters, pulse oximeters, weight scales, spirometers, and spirometers are continuously glucose monitoring devices.
HealthArc devices are FDA approved and 4G (2G fallback) cellular connected requiring no app pairing, making them easy for the patient to use and reliable in low-internet regions. They are issued by providers for seamless real-time monitoring and compliance ready billing.
Is the RPM device approved or cleared by the FDA? Does it send data in a safe fashion that follows HIPAA rules? Does it work with the EHR or RPM ecosystem? You should also put usability, device connectivity, and device reliability at the top of your list.
Although not all RPM systems require FDA approval, the use of non‑FDA-cleared devices poses challenges concerning data integrity and may have billing implications. For the best possible outcomes, cleared devices are preferable for use in clinical practice.
Bibliography
The “One Big Beautiful Bill,” signed July 4, 2025, directs $50B over...
Learn MoreIs your healthcare organization trying to pick a remote patient monitoring solution?...
Learn MoreWith a giant sweep taking place in the digital transformation of at-home...
Learn More